NEWTON, Mass. (AP) — NEWTON, Mass. (AP) — Karyopharm Therapeutics Inc. (KPTI) on Wednesday reported a loss of $37.4 million in its first quarter.

On a per-share basis, the Newton, Massachusetts-based company said it had a loss of 32 cents.

The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 33 cents per share.

The pharmaceutical company posted revenue of $33.1 million in the period, which missed Street forecasts. Four analysts surveyed by Zacks expected $35 million.

Karyopharm Therapeutics expects full-year revenue in the range of $140 million to $160 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KPTI at https://www.zacks.com/ap/KPTI